Evidence map›Paper›PMID 21699271›Full record

ReviewCNS drugs2011

Issues in the management of challenging behaviours of adults with autism spectrum disorder.

Johnny L Matson, Megan Sipes, Jill C Fodstad, Mary E Fitzgerald

Abstract readReview
PubMed Publisher
In one paragraph

Review in CNS drugs, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 4 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 4 syntheses or guidelines pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Psychoeducational Interventions for Adults With Level 3 Autism Spectrum Disorder: A 50-Year Systematic Review.Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology · 2019
    Pooled it
  3. Hyperbaric oxygen therapy for people with autism spectrum disorder (ASD).The Cochrane database of systematic reviews · 2016
    Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. The Factor Structure and Validity of the Psychopathy Checklist-Short Version When Used With Autistic Psychiatric Inpatients.Autism research : official journal of the International Society for Autism Research · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Prevalence of gastrointestinal symptoms among autistic individuals, with and without co-occurring intellectual disability.Autism research : official journal of the International Society for Autism Research · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Adults with Autism: Changes in Understanding Since DSM-111.Journal of autism and developmental disorders · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Johnny L MatsonDepartment of Psychology, Louisiana State University, Baton Rouge, LA, USA.
Megan Sipes
Jill C Fodstad
Mary E Fitzgerald
Louisiana State University · USNational Audubon Society · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism spectrum disorder (ASD) is a particularly important risk factor for challenging behaviours such as aggression, tantrums, self-injury and pica. Adults with ASD have rarely been studied with respect to these problems. This is particularly disconcerting since there are far more adults than children with ASD. In addition, because of adults' increased physical size and longer history of these problems, treating these behaviours effectively is important. Psychological methods, particularly applied behaviour analysis, and pharmacotherapy have been the most frequently addressed treatments for challenging behaviours associated with ASD in the research literature. In many cases, challenging behaviours have clear environmental antecedents. In these cases, behavioural interventions, such as applied behaviour analysis, should be used to reduce the behaviours. When environmental factors cannot be identified or when challenging behaviours are very severe, pharmacological treatments may be necessary in combination with behavioural interventions. Newer antipsychotics are the most researched medications for use with this population. Currently, risperidone and aripiprazole are the only medications that have US FDA approval for the treatment of behaviours associated with ASD, specifically irritability; however, they are indicated for use in children not adults. It is important not to use medications unnecessarily, due to possible side effects associated with their use. Based on available research, some recommendations for the treatment of challenging behaviours of adults (and children) with ASD include the use of functional assessment, side-effect monitoring of medications and behavioural methods whenever possible. Additionally, future research in this area needs to focus more on adults, as most current research has used child samples.

Indexed as

AdultAge FactorsAntipsychotic AgentsAripiprazoleBehavior TherapyChildChild Development Disorders, PervasiveCombined Modality TherapyHumansPiperazinesQuinolonesRisperidoneAntipsychotic AgentsAripiprazolePiperazinesQuinolonesRisperidone

Identifiers

PMID21699271
OpenAlexW2051721392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.